- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 12, 2025
Discovery & Translation
Pain targets in ion channel pathways: an Innovation Distillery spotlight
Upstream regulators of ion channel expression or function are an emerging frontier for novel pain targets
BioCentury | Jan 22, 2025
Deals
Simcere snaps up rights to Fermion’s analgesic, a potential Lilly competitor
BioCentury’s latest Deals Report also includes Regenxbio/Nippon, Merus/Biohaven and Daiichi Sankyo/Glycotope
BioCentury | Mar 2, 2023
Deals
Lilly adds to clinical pain pipeline via deal with Belgium’s Confo
Private European company gets $40M up front for AGTR2-targeting small molecule in Phase I; deal also includes preclinical antibody
BioCentury | May 28, 2019
Company News
Months after scuttling IPO bid, Centrexion adds to balance sheet with Lilly deal for pain therapy
Items per page:
1 - 10 of 11